Phase II Trial of Ontak With Metastatic Melanoma

Completed · Phase 2

Conditions studied: Malignant Melanoma

In brief

The purpose of this study is to determine whether ONTAK is an effective treatment in patients with Stage IV Melanoma

Key facts

Study ID

NCT00299689

Run by

James Graham Brown Cancer Center

People needed

69

Starts

2006-03-01

Expected to finish

2010-01-01

Last updated by the study team

2014-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• James Graham Brown Cancer Center, Univ. of Louisville — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.